Skip to main content
An official website of the United States government
Email

Myelodysplastic Syndromes (MDS) Workshop

Myelodysplastic Syndromes (MDS) Workshop, May 13 - 14, 2024 banner with a histological image of MDS

This workshop was held on May 13-14, 2024 and brought together senior leaders/experts,  junior investigators, and NCI staff who concentrate their research on Myelodysplastic Syndromes (MDS).

There are more than 10,000 new cases of MDS diagnosed in the U.S. every year. These blood cancers remain difficult to treat due to vast differences in the patient population including great genetic diversity, complicated clinical presentation with similarities to several overlap syndromes, and lack of highly effective and long-lasting treatments.

Presenters evaluated the current state of basic, preclinical and clinical sciences in this area, as well as identified key challenges and opportunities to foster MDS research and care.

Documents from the Workshop

Social media posts related to the workshop can be found using #Research4MDS.

DCB Contact for the Workshop

For additional information about the MDS Workshop, please contact Dr. Margaret (Gosia) Klauzinska.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Myelodysplastic Syndromes (MDS) Workshop was originally published by the National Cancer Institute.”

Email